Chemoinformaics analysis of 5,8-Dihydroxy-2,2-dimethylpyrano[3,2-b]xanthen-6-one
| Molecular Weight | 310.305 | nRot | 0 |
| Heavy Atom Molecular Weight | 296.193 | nRig | 22 |
| Exact Molecular Weight | 310.084 | nRing | 4 |
| Solubility: LogS | -3.641 | nHRing | 2 |
| Solubility: LogP | 4.306 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
| nHA | 5 | APOL | 43.4051 |
| nHD | 2 | BPOL | 18.3849 |
| QED | 0.621 |
| Synth | 2.875 |
| Natural Product Likeliness | 2.392 |
| NR-PPAR-gamma | 0.979 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.06 |
| Pgp-sub | 0.002 |
| HIA | 0.02 |
| CACO-2 | -4.753 |
| MDCK | 0.0000177 |
| BBB | 0.018 |
| PPB | 0.978212 |
| VDSS | 0.526 |
| FU | 0.0522635 |
| CYP1A2-inh | 0.946 |
| CYP1A2-sub | 0.599 |
| CYP2c19-inh | 0.606 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.82 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.865 |
| CYP2d6-sub | 0.566 |
| CYP3a4-inh | 0.616 |
| CYP3a4-sub | 0.146 |
| CL | 1.901 |
| T12 | 0.436 |
| hERG | 0.018 |
| Ames | 0.428 |
| ROA | 0.375 |
| SkinSen | 0.886 |
| Carcinogencity | 0.812 |
| EI | 0.802 |
| Respiratory | 0.615 |
| NR-Aromatase | 0.844 |
| Antiviral | Yes |
| Prediction | 0.688733 |